Last reviewed · How we verify

NCT03494894: BAVASI

Bacteriological Link Between Upper and Lower Airways in Cystic Fibrosis and Primary Ciliary Dyskinesia

Completed Last updated 4 August 2020
What this trial tests

trial testing Middle meatus aspirations and sputum in Cystic Fibrosis in 120 participants. Completed in 19 February 2019.

Timeline
1 June 2017
Primary endpoint
14 June 2017
19 February 2019

Quick facts

Lead sponsorCentre Hospitalier Intercommunal Creteil
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date1 June 2017
Primary completion14 June 2017
Estimated completion19 February 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Intercommunal Creteil

Who can join

6 and older, any sex, with Cystic Fibrosis or Primary Ciliary Dyskinesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cytobacteriological examination of sputum and bacteriological sampling in the middle meatus.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Follow-Up and Management of Chronic Rhinosinusitis in Adults with Primary Ciliary Dyskinesia: Review and Experience of Our Reference Centers.
    Bequignon E, Dupuy L, Escabasse V, Zerah-Lancner F, et al · · 2019 · cited 12× · PMID 31546861 · DOI 10.3390/jcm8091495

Verify or expand the search:

Other recruiting trials for Cystic Fibrosis

Currently open trials in the same condition.

Other Centre Hospitalier Intercommunal Creteil trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03494894.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing